Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
IV infusions support multi-nutrient customization
MD, Pediatrician, Regenerative Medicine Specialist
Leaders attributed the high MLR to elevated utilization in the ACA marketplace but also stressed that Cignas relatively strong position was due to Cignas decision, starting in 2023, to exit certain ACA markets in an effort to prioritize margin over growth. Like last quarter, Cignas performance was driven by strong specialty pharmacy growth in Cigna's Evernorth Health Services (i.e., non-insurance) division
And the starting doses, while lower, are being injected into tissue that has not adapted to regular subcutaneous medication administration
US$ 28.25
US$ 29.61
US$ 26.03
US$ 25.88
US$ 28.43
US$ 27.69
